Croda International (LON:CRDA) Reaches New 1-Year Low on Insider Selling

Shares of Croda International Plc (LON:CRDA - Get Free Report) hit a new 52-week low during mid-day trading on Tuesday following insider selling activity. The company traded as low as GBX 2,880 ($37.28) and last traded at GBX 2,893 ($37.44), with a volume of 332606 shares trading hands. The stock had previously closed at GBX 2,889 ($37.39).

Specifically, insider Steve Foots sold 3,249 shares of the stock in a transaction dated Monday, March 24th. The shares were sold at an average price of GBX 2,909 ($37.65), for a total value of £94,513.41 ($122,331.62).

Croda International Stock Performance

The company has a current ratio of 2.72, a quick ratio of 2.25 and a debt-to-equity ratio of 30.90. The firm has a market cap of £4.13 billion, a PE ratio of 25.40, a price-to-earnings-growth ratio of 1.40 and a beta of 0.74. The firm has a fifty day moving average price of GBX 3,172.65 and a 200 day moving average price of GBX 3,485.93.

Croda International (LON:CRDA - Get Free Report) last announced its quarterly earnings results on Tuesday, February 25th. The company reported GBX 142.60 ($1.85) EPS for the quarter. Croda International had a return on equity of 6.96% and a net margin of 9.98%. As a group, equities research analysts expect that Croda International Plc will post 181.8307268 earnings per share for the current fiscal year.

Croda International Increases Dividend

The company also recently declared a dividend, which will be paid on Wednesday, May 28th. Stockholders of record on Thursday, April 10th will be given a dividend of GBX 63 ($0.82) per share. This is a positive change from Croda International's previous dividend of $47.00. This represents a dividend yield of 2.03%. The ex-dividend date is Thursday, April 10th. Croda International's dividend payout ratio (DPR) is currently 93.66%.

Remove Ads

About Croda International

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.